The role of private equity firms in health | PwC's Next in Health

You must have a iHealthFlix subscription and be logged in to watch videos

Login or Subscribe

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s Deals Strategy & Pharma and Life Sciences Principal, Claire Love, on what role private equity firms play, in the rapid growth market of gene and cell therapies, including:

  • What are the growth drivers for private equity firms?
  • What technologies and innovations can be leveraged to increase supply chain efficiency?
  • Opportunities and risks private equity firms should consider
  • Improving collaboration between the pharmaceutical industry and private equity investors
Event Date: Friday, May 14, 2021

Speaker

Benjamin Isgur
Trine Tsouderos
Claire Love

Company

PwC Health Research Institute
PwC Health Research Institute
PricewaterhouseCoopers

Event Webpage (Available for subscribers only)


Category(s): Pharmaceutical

Format

Podcast

Contact Speaker / Organization (Available for subscribers only)